Skip to content
Extraction of liquid from scientific funnel
Extraction of liquid from scientific funnel

Life Sciences

Our Life Sciences group is a multi-disciplinary team of more than 90 lawyers drawn from across our global network.

We have a reputation for far-sighted advice to some of the world’s leading life science companies and are described as "an efficient and client-oriented team" in Chambers Global 2010 Life Sciences edition.

Our support for pharmaceuticals, biotech, medical devices, nursing homes and other healthcare-related companies, as well as financial institutions operating in the sector, covers the spectrum: mergers and acquisitions (M&A), commercial transactions, including licensing and collaborations, intellectual property (IP) protection and patent disputes, capital markets and finance, regulatory and private equity.

Our international network enables us to deploy the skills of market-leading experts in a number of jurisdictions and we are well placed to advise on cross-border work, both contentious and non-contentious.

News & insights

Close up of a modern green glass and metal building

Publications: 07 APRIL 2021

Compelling signals from a recovering M&A market

The question at the end of 2020 was whether the strong recovery in M&A activity could be sustained in 2021.

Read more
Close up of data screen with figures

News: 12 FEBRUARY 2021

Allen & Overy advises Biogroup on two high-yield bond issues and a new senior facilities agreement

PARIS – Biogroup, the leading private medical laboratory services group in France and Belgium, has successfully completed through its two main subsidiaries the issuance of EUR800million in aggregate…

Read more
Allen & Overy graphic

Publications: 24 NOVEMBER 2020

Covid-19 coronavirus and global employment law: Managing your workforce throughout the pandemic – part 3

In the third in our series of webinars, members of Allen & Overy’s Global Employment team discussed the significant issues and challenges that employers need to prioritise in relation to managing and…

Read more
health care sector

Publications: 03 JUNE 2020

Germany: Update on Foreign Direct Investment Screening - Health care sector becomes part of critical infrastructure

The German Foreign Direct Investment (FDI) screening rules were amended, bringing important parts of the health care sector under the regime applicable to critical infrastructure. Some, but not all,…

Read more

Life Sciences Hub

Legal and regulatory developments in the Life Sciences sector.

Recommended content